The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.
Influenza vaccine immunogenicity is diminished in patients living with HIV/AIDS. We evaluated the cost-effectiveness and expected value of perfect information (EVPI) of three alternative influenza vaccine dosing strategies intended to increase immunogenicity in those patients.A randomized, multi-cen...
Main Authors: | Bohdan Nosyk, Behnam Sharif, Huiying Sun, Curtis Cooper, Aslam H Anis, CIHR Canadian HIV Trials Network Influenza Vaccine Research Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3232195?pdf=render |
Similar Items
-
Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study
by: Charmaine M. McPherson, et al.
Published: (2018-08-01) -
High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada.
by: Lillian Lourenço, et al.
Published: (2014-01-01) -
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
by: International Collaboration on HIV and Cancer
Published: (2000) -
The evolving landscape of the economics of HIV treatment and prevention.
by: Bohdan Nosyk, et al.
Published: (2012-02-01) -
Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda
by: Kimathi, D, et al.
Published: (2019)